The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040Takanori Ito, Mindie H. Nguyen, Yuichiro Eguchi et al.|Hepatology International|2021Cited by 151
Artificial intelligence-based diagnosis of upper gastrointestinal subepithelial lesions on endoscopic ultrasonography imagesKeiko Hirai, Mitsuhiro Fujishiro, Takamichi Kuwahara et al.|Gastric Cancer|2021Cited by 81
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignanciesKazuyuki Mizuno, Mitsuhiro Fujishiro, Takanori Ito et al.|Journal of Gastroenterology|2020Cited by 74
Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effectsMitsuhiro Kawakubo, Takayoshi Suganami, Miyako Tanaka et al.|Scientific Reports|2020Cited by 72
Sorafenib <i>vs</i>. Lenvatinib as First-line Therapy for Advanced Hepatocellular Carcinoma With Portal Vein Tumor ThrombosisTeiji Kuzuya, Mitsuhiro Fujishiro, Masatoshi Ishigami et al.|Anticancer Research|2020Cited by 53